Pediatric Oncology Flashcards
1
Q
Initial Testing based on Presentation
A
- CXR - mediastinal mass
- US/CT of abdomen - abdominal tumor
- Brain CT
- CBC - pancytopenia or lymphocytosis
- peripheral smear - immature forms (blasts)
2
Q
MC Childhood Malignancies
A
- ALL / AML (25%)*
- CNS tumors (17%)
- Neuroblastoma (7%)
- Wilms
- Non-Hodgkin lymphoma
- Hodgkins
- Rhabdomyosarcoma
- Osteosarcoma
- Ewing
3
Q
Causes/Types of Leukemia
A
- causes
- unknown
- predisposed- Downs, Wiskott Aldrich syndrome, neurofibromatosis
- sibling w/ leukemia
- radiation/chemotherapy
- types
- Acute Lymphoblastic (ALL) - 75%
- Acute Myelogenous (AML) - 15%
- Chronic Myelogenous (CML)
4
Q
Classification of ALL
A
based on morphology of cancerous cells
- B cell lineage
- T cell lineage
- Burkitts lymphoma
- MC in boys than girls
- peaks at age 2-5
5
Q
Classification of AML
A
based cell types involved in proliferation
- AML without maturation
- AML with maturation
- myelomonocytic
- monoblastic and monocytic
- erythroid
- megakaryoblastic
- basophylic
- panmyelosis w/ myelofibrosis
6
Q
Presentation of Leukemia*
A
- fever
- pallor
- bruising or petechiae
- lethargy or malaise
- anorexia
- bone or joint pain
7
Q
Physical Findings in Leukemia
A
- weight loss
- ill appearance, fatigue
- cough (secondary to mediastinal involvement)
- pallor (secondary to anemia)
- lymphadenopathy
- abdominal mass, splenomegaly
- testicular mass
- various soft tissue tumors in AML
8
Q
Evaluation of Leukemia
A
- immature blasts on peripheral smear
- urgent consultation
- bone marrow aspiration (dx confirmation)
- LP to determine CNS spread
- cytogenetic analysis to begin tx planning
9
Q
ALL Chemo
A
- 3-4 agents
- IV or intrathecally for CNS
- 2-3 years
10
Q
AML Chemo
A
- intensive myelosuppressive therapy
- may need stem cell transplant (HLA matched sibling)
11
Q
ALL Prognosis
A
- overall cure rate 80%
- low, standard, high, very high
- based on age, initial WBC count, genetics, response to induction therapy
- relapse during tx poor prognostic sign
- relapse can be bone marrow, CNS, testes, other site
12
Q
AML Prognosis
A
- 50% cure rate
- improved with HLA matched stem cell transplantation from sibling
13
Q
Hodgkin’s Disease
S/s, Dx, Tx
A
- bimodal distribution
- adolescent/young adult and >50
- S/s
- firm, painless lymph node in 1-2 areas
- usually supraclavicular, cervical
- mediastinal w/ cough and SOB
- abdominal w/ pain
- suspected w/ EBV infection
- firm, painless lymph node in 1-2 areas
- Dx
- CBC, ESR, electolytes, Ca+, phosphorous, LDH, uric acid, CXR
- biopsy of affected tissue
- Reed Sternberg cells*
- Tx
- combo chemo and irradiation
- 90% overall 5 year survival
14
Q
Non-Hodgkin Lymphoma
characteristics / subtypes
A
- subtypes
- lymphoblastic lymphoma
- small noncleaved cell lymphoma
- large cell lymphoma
- characteristics
- suspected assoc. w/ EBV - focal lymph nodes
- typically systemic - bulky extramedullary disease
15
Q
CNS Tumor Presentation
A
2nd MC tumor in children
- HA (usually later)
- altered mental status
- ataxia
- NAV, weight loss
- gait disturbance
- focal seizures
- visual changes
- speech deficits
- focal sensory abnormalities